Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05006989 · ClinicalTrials.gov registry record · NA

Blueberry Intake and Infant Gut Health

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT05006989: Completed NA study, sponsored by University of Colorado, Denver.

NCT05006989 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05006989, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The objective of this project is to investigate the effects of blueberries on gut microbiota, inflammation and innate immunity in breastfed infants during early complementary feeding (\~5 to 12 months of age).

Primary Outcome

16S rRNA amplicon sequencing is used to profile taxonomic makeup of fecal specimens. Within the gut microbiome composition, microbial diversity will be summarized using common ecological measures (Good's coverage, Sobs, and Shannon alpha diversity).

Interventions

  • OTHER Placebo Powder
  • OTHER Blueberry Powder

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-09-01
Est. Completion 2025-03-30
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT05006989 record still lists

NCT05006989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo Powder is the first listed.

NCT05006989 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05006989 about?

NCT05006989 is a clinical study titled "Blueberry Intake and Infant Gut Health". The objective of this project is to investigate the effects of blueberries on gut microbiota, inflammation and innate immunity in breastfed infants during early complementary feeding (\~5 to 12 months of age).

What is the current status of trial NCT05006989?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-09-01. Estimated completion is 2025-03-30.

What interventions are being tested in trial NCT05006989?

The interventions under investigation include: Placebo Powder (OTHER), Blueberry Powder (OTHER).

Who is sponsoring clinical trial NCT05006989?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05006989's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05006989, the US trial registry maintained by the National Library of Medicine. NCT05006989 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.